Literature DB >> 28826839

Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.

Nora C Pyenson1, Kaitlyn Gayvert2, Andrew Varble1, Olivier Elemento3, Luciano A Marraffini4.   

Abstract

CRISPR loci are a cluster of repeats separated by short "spacer" sequences derived from prokaryotic viruses and plasmids that determine the targets of the host's CRISPR-Cas immune response against its invaders. For type I and II CRISPR-Cas systems, single-nucleotide mutations in the seed or protospacer adjacent motif (PAM) of the target sequence cause immune failure and allow viral escape. This is overcome by the acquisition of multiple spacers that target the same invader. Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system does not require PAM or seed sequences, and thus prevents viral escape via single-nucleotide substitutions. Instead, viral escapers can only arise through complete target deletion. Our work shows that, as opposed to type I and II systems, the relaxed specificity of type III CRISPR-Cas targeting provides robust immune responses that can lead to viral extinction with a single spacer targeting an essential phage sequence.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas; Csm; adaptive immunity; bacteria; bacteriophage; plasmid conjugation; staphylococcus

Mesh:

Substances:

Year:  2017        PMID: 28826839      PMCID: PMC5599366          DOI: 10.1016/j.chom.2017.07.016

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  50 in total

1.  Sorting of protein A to the staphylococcal cell wall.

Authors:  O Schneewind; P Model; V A Fischetti
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs.

Authors:  Asma Hatoum-Aslan; Poulami Samai; Inbal Maniv; Wenyan Jiang; Luciano A Marraffini
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

3.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

4.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

Review 5.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

6.  RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.

Authors:  Raymond H J Staals; Yifan Zhu; David W Taylor; Jack E Kornfeld; Kundan Sharma; Arjan Barendregt; Jasper J Koehorst; Marnix Vlot; Nirajan Neupane; Koen Varossieau; Keiko Sakamoto; Takehiro Suzuki; Naoshi Dohmae; Shigeyuki Yokoyama; Peter J Schaap; Henning Urlaub; Albert J R Heck; Eva Nogales; Jennifer A Doudna; Akeo Shinkai; John van der Oost
Journal:  Mol Cell       Date:  2014-11-06       Impact factor: 17.970

7.  An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.

Authors:  Wenfang Peng; Mingxia Feng; Xu Feng; Yun Xiang Liang; Qunxin She
Journal:  Nucleic Acids Res       Date:  2014-12-10       Impact factor: 16.971

8.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

9.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

10.  Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.

Authors:  Gregory W Goldberg; Wenyan Jiang; David Bikard; Luciano A Marraffini
Journal:  Nature       Date:  2014-08-31       Impact factor: 49.962

View more
  49 in total

1.  Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Authors:  Ning Jia; Charlie Y Mo; Chongyuan Wang; Edward T Eng; Luciano A Marraffini; Dinshaw J Patel
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

2.  Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.

Authors:  Ling Wang; Charlie Y Mo; Michael R Wasserman; Jakob T Rostøl; Luciano A Marraffini; Shixin Liu
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

3.  Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.

Authors:  Tong Guo; Wenyuan Han; Qunxin She
Journal:  RNA Biol       Date:  2018-07-09       Impact factor: 4.652

4.  Selective Maintenance of Multiple CRISPR Arrays Across Prokaryotes.

Authors:  Jake L Weissman; William F Fagan; Philip L F Johnson
Journal:  CRISPR J       Date:  2018-12

5.  A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.

Authors:  Saifu Pan; Qi Li; Ling Deng; Suping Jiang; Xuexia Jin; Nan Peng; Yunxiang Liang; Qunxin She; Yingjun Li
Journal:  RNA Biol       Date:  2019-05-26       Impact factor: 4.652

6.  The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.

Authors:  Leah M Smith; Simon A Jackson; Lucia M Malone; James E Ussher; Paul P Gardner; Peter C Fineran
Journal:  Nat Microbiol       Date:  2021-01-04       Impact factor: 17.745

7.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

8.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

9.  Cas13 Helps Bacteria Play Dead when the Enemy Strikes.

Authors:  Senén D Mendoza; Joseph Bondy-Denomy
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

Review 10.  Three New Cs for CRISPR: Collateral, Communicate, Cooperate.

Authors:  Andrew Varble; Luciano A Marraffini
Journal:  Trends Genet       Date:  2019-04-27       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.